Medical News
American
Medical News for 8 April 2026
Daratumumab or Active Monitoring for High-Risk Smoldering Multiple Myeloma
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, Page 1456-1456, April 9, 2026.
Case 10-2026: A 70-Year-Old Woman with a Racing Heart, Fatigue, and Dyspnea
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, Page 1431-1441, April 9, 2026.
Immunogenicity and Safety of vYF, a Yellow Fever Vaccine - A Phase 2 Trial
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, Page 1399-1408, April 9, 2026.
Necrolytic Migratory Erythema
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, Page 1430-1430, April 9, 2026.
Multifaceted Strategies for Hypertension Control in Low-Income Patients
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, Page 1376-1387, April 9, 2026.
CD19 CAR T-Cell Therapy for Autoimmune Hemolytic Anemia
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, Page 1455-1455, April 9, 2026.
Systems-Based Success for Hypertension
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, Page 1445-1446, April 9, 2026.
High-Dose Influenza Vaccine and Hospitalizations in Older Adults
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, Page 1453-1454, April 9, 2026.
Measles 2025
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, Page 1456-1456, April 9, 2026.
Altering the Diet to Rewire Cancer
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, Page 1447-1450, April 9, 2026.
More about the Phase 2a Study of Baxdrostat in Primary Aldosteronism
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, Page 1456-1456, April 9, 2026.
The Whole Patient - Toward Holistic, High-Value Care
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, April 9, 2026.
A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia
New England Journal of Medicine - 8 Apr 2026 09:00
New England Journal of Medicine, Volume 394, Issue 14, Page 1388-1398, April 9, 2026.
Global
Great Britain
Indian
South Africa